Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
Roloff GW, Wen F, Ramsland A, Artz AS, Kosuri S, Stock W, Odenike O, Larson RA, Liu H, Godley LA, Thirman MJ, Patel AA, Daugherty CK, DuVall AS, Nawas MT, Dworkin E, Wool GD, Gurbuxani S, Fitzpatrick C, Segal JP, Wang P, Drazer MW.
Roloff GW, et al. Among authors: daugherty ck.
Haematologica. 2023 Aug 1;108(8):2234-2239. doi: 10.3324/haematol.2022.282148.
Haematologica. 2023.
PMID: 36655425
Free PMC article.
No abstract available.